Ana Márquez
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Immunology top 10%
- T-cell and B-cell Immunology
Papers in
- Immunology 20
- T-cell and B-cell Immunology 6
- Immunodeficiency and Autoimmune Disorders 5
- Rheumatology 16
- Systemic Lupus Erythematosus Research 7
- Rheumatoid Arthritis Research and Therapies 5
- Co-authors
- Javier Martı́n (35 shared papers)Inna Sekirov (7 shared papers)Sriram Subramaniam (1 shared paper)Xing Zhu (1 shared paper)Katharine S. Tuttle (1 shared paper)Alison Berezuk (1 shared paper)James W. Saville (1 shared paper)Shanti Swaroop Srivastava (1 shared paper)
- Journals
- Frontiers in Immunology (7 papers)Annals of the Rheumatic Diseases (3 papers)Inflammatory Bowel Diseases (3 papers)Microbiology Spectrum (3 papers)PLoS ONE (2 papers)
- Partner nations
- SpainCanadaUnited Kingdom
In The Last Decade
Ana Márquez
67 papers receiving 1.5k citations
Ana Márquez's Hit Papers
Peers
Comparison fields: 5 of 96
- Infectious Diseases 433
- Immunology 362
- Rheumatology 221
- Gastroenterology 50
- Genetics 234
Countries citing papers authored by Ana Márquez
This map shows the geographic impact of Ana Márquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Márquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Márquez more than expected).
Fields of papers citing papers by Ana Márquez
This network shows the impact of papers produced by Ana Márquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Márquez. The network helps show where Ana Márquez may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Márquez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex Hit paper breakdown → | 2022 | 420 |
| 2 | 2008 | 102 | |
| 3 | 2018 | 67 | |
| 4 | 2013 | 54 | |
| 5 | 2007 | 46 | |
| 6 | 2010 | 45 | |
| 7 | 2022 | 43 | |
| 8 | 2009 | 42 | |
| 9 | 2016 | 39 | |
| 10 | 2009 | 39 | |
| 11 | 2018 | 37 | |
| 12 | 2008 | 37 | |
| 13 | 2008 | 34 | |
| 14 | 2013 | 32 | |
| 15 | 2022 | 28 | |
| 16 | 2015 | 26 | |
| 17 | 2006 | 22 | |
| 18 | 2021 | 22 | |
| 19 | 2015 | 22 | |
| 20 | 2009 | 19 |
About Ana Márquez
Ana Márquez is a scholar working on Immunology, Rheumatology, Infectious Diseases, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 71 papers that have together received 1.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), Vasculitis and related conditions (12 papers), Systemic Lupus Erythematosus Research (7 papers), COVID-19 Clinical Research Studies (6 papers), T-cell and B-cell Immunology (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Inflammatory Bowel Disease (5 papers). The work is most often cited by research in Infectious Diseases (433 citations), Immunology (362 citations), Rheumatology (221 citations), Gastroenterology (50 citations) and Genetics (234 citations). Ana Márquez has collaborated with scholars based in Spain, Canada and United Kingdom. Frequent co-authors include Javier Martı́n, Inna Sekirov, Sriram Subramaniam, Xing Zhu, Katharine S. Tuttle, Alison Berezuk, James W. Saville, Shanti Swaroop Srivastava, Dhiraj Mannar and Elena Urcelay. Their work appears in journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases, Inflammatory Bowel Diseases, Microbiology Spectrum and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.